Bone Biologics Corp (BBLG)

Bone Biologics Corp Azioni (BBLG) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	22.11% 0.9035	1.16	2.0809	3.0399	3.1475
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	22.11% -0.9035	-1.16	-2.0809	-3.0399	-3.1475
Net Interest Income/Expense	0.000255	-	-	-	-
Nonoperating Income/Loss	0.0376	-	-	-	-
Income/Loss From Continuing Operations Before Tax	44.13% -0.866	-1.5499	-1.9197	-1.7692	-3.7099
Income/Loss From Continuing Operations After Tax	44.13% -0.866	-1.5499	-1.9197	-1.7692	-3.7099
Net Income/Loss	44.13% -0.866	-1.5499	-1.9197	-1.7692	-3.7099
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	150.10% 0.6609	-1.3193	3.1344	1.047	16.12
Diluted Average Shares	150.10% 0.6609	-1.3193	3.1344	1.047	-0.2535
Basic Earnings Per Share	95.53% -1.31	-29.33	-0.61	-1.69	-0.23
Diluted Earnings Per Share	95.53% -1.31	-29.33	-0.61	-1.69	-5.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-